Statistics
Publications
21
Citations
2.1K
H-Index
17
Active since
1997
Gejing Deng is an author at Sanofi (United States) specializing in life sciences, molecular biology, and biochemistry.
Publications per year
1997–2022
21
21
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion
Kensuke Tateishi, Hiroaki Wakimoto, A. John Iafrate et al. · Cancer Cell · 2015 · 445 citations · Full text
Medicine, Cancer Biology, Oncology +16
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques
Ling Xu, Amarendra Pegu, Ercole Rao et al. · Science · 2017 · 271 citations · Full text
Michael Lampa, Heike Arlt, Timothy He et al. · PLoS ONE · 2017 · 168 citations · Full text
A trispecific antibody targeting HER2 and T cells inhibits breast cancer growth via CD4 cells
Edward Seung, Zhen Xing, Lan Wu et al. · Nature · 2022 · 152 citations
Medicine, Cancer Biology, Oncology +17
1–5 of 21